IL-6-174 G/C and ApoE gene polymorphisms in Alzheimer's and vascular dementia patients attending the cognitive disorder clinic of the all India Institute of Medical Sciences, New Delhi

Dementia and Geriatric Cognitive Disorders

Volumn 30, Issue 6, 2011, Pages 461-468

  Mansoori, Nasim ^a   Tripathi, Manjari ^a   Alam, Rizwan ^a,b   Luthra, Kalpana ^a   Ramakrishnan, Lakshmy ^a   Parveen, Shama ^b   Mukhopadhyay, Asok K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Alzheimer's disease; Apolipoprotein E; Dementia; Interleukin 6; Neurodegenerative disease; Polymorphism; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E; INTERLEUKIN 6;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; REGRESSION ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COGNITION DISORDERS; DEMENTIA, VASCULAR; DNA; FEMALE; GENOTYPE; HUMANS; INDIA; INTERLEUKIN-6; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79251503004     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321666     Document Type: Article

References (44)

1. Shaji S, Promodu K, Abraham T, Roy KJ, Verghese A: An epidemiological study of dementia in a rural community in Kerala, India. Br J Psychiatry 1996; 168: 745-749.
2. Zhang MY, Katzman R, Salmon D, et al: The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 1990; 27: 428-437.
3. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang ZX, Antuono P, World Federation of Neurology Dementia Research Group: Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 2008; 7: 812-826.
4. Thakur MK: Alzheimer's disease: a challenge in new millennium. Curr Sci 2000; 79: 29-36.
5. Saunders AM, Strittmatter WJ, Schmechel D, et al: Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-1472. (Pubitemid 23230526)
6. Papassotiropoulos A, Streffer JR, Hock C, Nitsch RM: Genetics of Alzheimer's disease. Schweiz Arch Neurol Psychiatr 2001; 152: 278-287.
7. Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO: APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. BMC Neurology 2008,8: 9.
8. Frank A, Díez-Tejedor E, Bullido MJ, Valdivieso F, Barreiro P: APOE genotype in cerebrovascular disease and vascular dementia. J Neurol Sci 2002; 203-204: 173-176.
9. Orsitto G, Seripa D, Panza F, Franceschi M, Cascavilla L, Placentino G, Matera MG, Paris F, Capurso C, Solfrizzi V, Dallapiccola B, Pilotto A: Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia. Dement Geriatr Cogn Disord 2007; 23: 327-333.
10. Chapman J, Wang N, Treves TA, Korczyn AD, Bornstein NM: ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke 1998; 29: 1401-1404.
11. Katzman R, Zhang MY, Chen PJ, Gu N, Jiang S, Saitoh T, Chen X, Klauber M, Thomas RG, Liu WT, Yu ES: Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia. Neurology 1997; 49: 779-785.
12. Vitek MP, Brown CM, Colton CA: APOE genotype-specific differences in the innate immune response. Neurobiol Aging 2009; 30: 1350-1360.
13. Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, Ueki A, Nagao M, Arai H: Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 2002; 114: 436-439.
14. Mateo I, Infante J, Rodríguez E, Berciano J, Combarros O, Llorca J: Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk. J Neurol Neurosurg Psychiatry 2006; 77: 278-279. (Pubitemid 43220866)
15. Pola R, Flex A, Gaetani E, Lago AD, Gerardino L, Pola P, Bernabei R: The-174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected]. Neuroreport 2002; 13: 1645-1647.
16. Licastro F, Grimaldi LM, Bonafe M, Martina C, Olivieri F, Cavallone L, Giovanietti S, Masliah E, Franceschi C: Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol Aging 2003; 24: 921-926.
17. Arosio B, Trabattoni D, Galimberti L, Bucciarelli P, Fasano F, Calabresi C, Cazzullo CL, Vergani C, Annoni G, Clerici M: Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol Aging 2004; 25: 1009-1015. (Pubitemid 38798062)
18. Licastro F, Porcellini E, Caruso C, Lio D, Corder EH: Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging 2007; 28: 1637-1643.
19. Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, Hosford D, Barnes MR, Briley JD, Borrie M, Coletta N, Delisle R, Dhalla D, Ehm MG, Feldman HH, Fornazzari L, Gauthier S, Goodgame N, Guzman D, Hammond S, Hollingworth P, Hsiung GY, Johnson J, Kelly DD, Keren R, Kertesz A, King KS, Lovestone S, Loy-English I, Matthews PM, Owen MJ, Plumpton M, Pryse-Phillips W, Prinjha RK, Richardson JC, Saunders A, Slater AJ, St George-Hyslop PH, Stinnett SW, Swartz JE, Taylor RL, Wherrett J, Williams J, Yarnall DP, Gibson RA, Irizarry MC, Middleton LT, Roses AD: Candidate singlenucleotide polymorphisms from a genome wide association study of Alzheimer disease. Arch Neurol 2008; 65: 45-53.
20. Ravaglia G, Paola F, Maioli F, Martelli M, Montesi F, Bastagli L, Bianchin M, Chiappelli M, Tumini E, Bolondi L, Licastro F: Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study. Exp Gerontol 2006; 41: 85-92.
21. Depboylu C, Lohmuller F, Gocke P, Du Y, Zimmer R, Gasser T, Klockgether T, Dodel RC: An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease. Dement Geriatr Cogn Disord 2004; 17: 170-173.
22. Bagli M, Papassotiropoulos A, Knapp M, Jessen F, Luise Rao M, Maier W, Heun R: Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population. Neurosci Lett 2000; 283: 109-112.
23. Zhang Y, Hayes A, Pritchard A, Thaker U, Haque MS, Lemmon H, Harris J, Cumming A, Lambert JC, Chartier-Harlin MC, St Clair D, Iwatsubo T, Mann DM, Lendon CL: Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease. Neurosci Lett 2004; 362: 99-102.
24. Koivisto AM, Helisalmi S, Pihlajamaki J, Moilanen L, Kuusisto J, Laakso M, Hiltunen M, Keijo K, Hanninen T, Helkala EL, Kervinen K, Kesaniemi YA, Soininen H: Interleukin-6 promoter polymorphism and lateonset Alzheimer's disease in the Finnish population. J Neurogenet 2005; 19: 155-161.
25. Van Oijen M, Arp PP, de Jong FJ, Hofman A, Koudstaal PJ, Uitterlinden AG, Breteler MM: Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study. Neurosci Lett 2006; 402: 113-117.
26. Capurso C, Solfrizzi V, Colacicco AM, D'Introno A, Frisardi V, Imbimbo BP, Lorusso M, Vendemiale G, Denitto M, Santamato A, Seripa D, Pilotto A, Fiore P, Capurso A, Panza F: Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 177-182.
27. Angelis P, Scharf S, Mander A, Vajda F, Christophidis N: Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease. Neurosci Lett 1998; 244: 106-108.
28. Lanzrein AS, Johnston CM, Perry VH, Jobst KA, King EM, Smith AD: Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. Alzheimer Dis Assoc Disord 1998; 12: 215-227.
29. Valente C, Maione P, Lippi A, et al: Validation of the Mini-Mental State Examination (MMSE) as a screening instrument for dementia in an Italian population. Giorn Gerontol 1992; 40: 161-5.
30. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215.
31. Wenham PR, Price WH, Blundell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337: 1158-1159.
32. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376.
33. Janka Z, Juhász A, Rimanóczy A A, Boda K, Márki-Zay J, Kálmán J: Codon 311 (Cys - 1 Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias. Mol Psychiatry 2002; 7: 110-112.
34. Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T: Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Neurosci Lett 2005; 375: 1-6.
35. Pandey P, Pradhan S, Mittal B: Presenilin gene predisposes to late-onset degenerative but not vascular dementia: a comparative study of PS1 and ApoE genes in a North Indian Cohort. Dement Geriatr Cogn Disord 2007; 24: 151-161.
36. Luthra K, Tripathi M, Grover R, Dwivedi M, Kumar A, Dey AB: Apolipoprotein E gene polymorphism in Indian patients with Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 2004; 17: 132-135.
37. Pirttilä T, Lehtimäki T, Rinne J, Mattila K, Frey H, Nikkari T: The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Acta Neurol Scand 1996; 93: 352-354.
38. Pola R, Gaetani E, Flex A, Aloi F, Papaleo P, Gerardino L, De Martini D, Flore R, Pola P, Bernabei R:-174 G/C interleukin-6 gene polymorphism and increased risk of multiinfarct dementia: a case-control study. Exp Gerontol 2002; 37: 949-955.
39. Rao KM, Pieper CS, Currie MS, Cohen HJ: Variability of plasma IL-6 and cross linked fibrin dimers over time in community dwelling elderly subjects. Am J Clin Pathol 1994; 102: 802-805.
40. Ershler WB, Keller ET: Age-associated increased interleukin-6 gene expression, latelife diseases, and frailty. Annu Rev Med 2000; 51: 245-270.
41. Krabbe KS, Pedersen M, Bruunsgaard H: Inflammatory mediators in the elderly. Exp Gerontol 2004; 39: 687-699.
42. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D: Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 292: 1440-1446.
43. Kopp HP, Kopp CW, Festa A, Kryzanowska K, Kriwanek S, Minar E, Roka R, Schernthaner G: Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thomb Vasc Biol 2003; 23: 1042-1047.
44. Kaur G, Rapthap CC, Kumar N, Kumar S, Neolia S, Mehra NK: Frequency distribution of cytokine gene polymorphisms in the healthy North Indian population. Tissue Antigens 2007; 69: 113-120.